Page 4 - Nasdaq Dyn News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq dyn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Dyn Today - Breaking & Trending Today

Insider Selling: Dyne Therapeutics, Inc. (NASDAQ:DYN) SVP Sells 13,000 Shares of Stock

Dyne Therapeutics, Inc. (NASDAQ:DYN – Get Free Report) SVP Richard William Scalzo sold 13,000 shares of the business’s stock in a transaction that occurred on Friday, January 26th. The stock was sold at an average price of $24.34, for a total value of $316,420.00. Following the transaction, the senior vice president now directly owns 124,228 […] ....

United States , Raymond James , Richard William Scalzo , Blackrock Inc , Dyne Therapeutics Inc , Securities Exchange Commission , Vr Adviser , Goldman Sachs Group Inc , Dyne Therapeutics , Get Free Report , William Scalzo , Exchange Commission , Street Corp , Goldman Sachs Group , Sachs Group , Dyne Therapeutics Daily , Nasdaq Dyn , Insider Trading , Nsider Trades ,

Dyne Therapeutics, Inc. (NASDAQ:DYN) SVP Richard William Scalzo Sells 13,000 Shares of Stock

Dyne Therapeutics, Inc. (NASDAQ:DYN – Get Free Report) SVP Richard William Scalzo sold 13,000 shares of the business’s stock in a transaction that occurred on Friday, January 26th. The shares were sold at an average price of $24.34, for a total transaction of $316,420.00. Following the completion of the sale, the senior vice president now […] ....

United States , Zurcher Kantonalbank Zurich Cantonalbank , Raymond James , Richard William Scalzo , Royal Bank , Sphera Funds Management , China Universal Asset Management Co , Dyne Therapeutics Inc , Dyne Therapeutics Company Profile , Ameritas Investment Partners Inc , Dyne Therapeutics , Get Free Report , William Scalzo , Investment Partners , Universal Asset Management , Funds Management , Kantonalbank Zurich Cantonalbank , Dyne Therapeutics Daily , Nasdaq Dyn , Insider Trading , Nsider Trades ,

Dyne Therapeutics (NASDAQ:DYN) Hits New 52-Week High at $25.50

Dyne Therapeutics, Inc. (NASDAQ:DYN – Get Free Report) hit a new 52-week high during trading on Friday . The stock traded as high as $25.50 and last traded at $22.45, with a volume of 2964254 shares trading hands. The stock had previously closed at $17.90. Wall Street Analysts Forecast Growth A number of equities research […] ....

United States , Joshuat Brumm , Raymond James , Dirk Kersten , Ameritas Investment Partners Inc , Mirae Asset Global Investments Co , Deutsche Bank , Securities Exchange Commission , Principal Financial Group Inc , Dyne Therapeutics Inc , Dyne Therapeutics , Get Free Report , Director Dirk Kersten , Exchange Commission , Financial Group , Investment Partners , Asset Global Investments , Dyne Therapeutics Daily , Nasdaq Dyn ,

Dyne Therapeutics Announces Proposed Public Offering of

WALTHAM, Mass., Jan. 03, 2024 (GLOBE NEWSWIRE) Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing. ....

New York , United States , San Francisco , Amy Reilly , Stacy Nartker , Raymond James , Prospectus Department , Broadridge Financial Solutions , Oppenheimer Co , Jp Morgan Securities , Morgan Stanley Co , Equity Syndicate Prospectus Department , Morgan Stanley , Exchange Commission , Nicolaus Company Incorporated , Island Avenue , One Montgomery Street , Private Securities Litigation Reform Act , Nasdaq Dyn , Dyne Therapeutics ,

Insider Selling: Dyne Therapeutics, Inc. (NASDAQ:DYN) Insider Sells 10,000 Shares of Stock

Dyne Therapeutics, Inc. (NASDAQ:DYN – Get Rating) insider Richard William Scalzo sold 10,000 shares of the company’s stock in a transaction that occurred on Thursday, June 15th. The shares were sold at an average price of $12.03, for a total value of $120,300.00. Following the completion of the sale, the insider now owns 43,482 shares […] ....

United States , Richard William Scalzo , Raymond James , Securities Exchange Commission , Allspring Global Investments Holdings , Dyne Therapeutics Inc , Tower Research Capital , Group Plc , Dyne Therapeutics Company Profile , Sphera Funds Management , Dyne Therapeutics , Get Rating , Exchange Commission , Therapeutics Trading Down , Global Investments Holdings , Funds Management , General Group Plc , Research Capital , Dyne Therapeutics Daily , Nasdaq Dyn , Insider Trading , Nsider Trades ,